Connect with us
European Gaming Congress 2024

Artificial Intelligence

ASEAN and South Asia Mammography Systems Market is Expected to Reach a Value of USD 834.40 Billion by Growing at a CAGR of 12% During 2022-2028; Growing Prevalence of Breast Cancer to Elevate Market Growth

Published

on

<!– Name:DistributionId Value:8752663 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1257425 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:43011237-2053-4f57-a6ab-368eec2d8f08 –>

Westford, USA, Feb. 21, 2023 (GLOBE NEWSWIRE) — The ASEAN and South Asia mammography systems market in China is estimated to gather the largest market share during the forecast period. The growing prevalence of breast cancer and rising awareness among the female population regarding the health threats of breast cancer is predicted to drive market growth during the forecast period. Additionally, the growing efforts by the government in encouraging investment in welfare programs and creating national-level diagnostic programs for better detection are anticipated to positively influence market growth over the ensuing years.

SkyQuest’s latest insights show that China, the greatest developing nation, has a relatively high incidence of breast cancer internationally, especially in urban areas, this incidence has climbed more than twice as quickly as the global rate. In 2020 the major incidences of all cancers among Chinese females, with a rate of 37.7 per 100,000 was found to be breast cancer, making it one of the widely spreading chronic diseases in the region. Hence, the need for solid and accurate mammography systems is predicted to rise in the area during the forecast period.

Browse in-depth TOC on “ ASEAN and South Asia Mammography Systems Market”

Pages – 225

Advertisement

Tables – 89

Figures – 70

Get a sample copy of this report:

https://skyquestt.com/sample-request/mammography-systems-market

An x-ray imaging technique called mammography is used to inspect the breast in order to check for early signs of breast illnesses like tumors. It functions as a screening and diagnostic tool. An image detector, an x-ray generator, and mammary compressive paddles are all necessary parts of a mammogram. Although the x-ray emitter and image sensor are fixed and orthogonally orientated to one another, the entire section can be pivoted to acquire the necessary mammographic views.

Advertisement

Prominent Players in ASEAN and South Asia Mammography Systems Market

  • Hologic, Inc. (US)
  • Analogic Corporation (US)
  • Canon Medical Systems Corporation (Japan)
  • Canon Inc. (Japan)
  • Carestream Health, Inc. (US)
  • Delphinus Medical Technologies (US)
  • Fujifilm Holdings Corporation (Japan)
  • Ge Healthcare (US)
  • Siemens Healthineers (Germany)
  • Ims Giotto SpA (Italy)
  • Konica Minolta Healthcare Americas, Inc. (US)
  • Koninklijke Phillips N.V. (Netherlands)
  • NP JSC AMICO (Russia)
  • Planmed (Finland)
  • Toshiba Medical Systems (Japan)

Browse summary of the report and Complete Table of Contents (ToC):

https://skyquestt.com/report/mammography-systems-market

Breast Tomosynthesis system Segment to Grow at a Notable CAGR Owing to Its Significant Benefits over Conventional System

The breast tomosynthesis system segment of the ASEAN and South Asia mammography systems market is predicted to garner significant market share by growing at a notable CAGR during the forecast period. The growth of the segment can be ascribed to the increasing adoption of this method over traditional scanning methods owing to its significant benefits. The need for breast tomosynthesis equipment is fueled by ongoing improvements in clinical outcomes and high-quality breast tissue imaging. The tool can prevent the development of advanced cancer and detect early signs of cancer. The main advantage of this device is that it can improve the visibility of normal tissue and breast abrasions by lessening the concealing effects of surrounding fibro glandular tissue. These are a few of the key contributing aspects to the segment’s dominance, and they are anticipated to fuel market expansion over the study period.

Moreover, the mammography systems market in India is estimated to witness noteworthy growth during the forecast period. The growing prevalence of breast cancer, rising healthcare expenditure, and increasing technological advancements in the field of medical devices in the region are estimated to boost market growth during the forecast period.

Advertisement

SkyQuest’s latest research reports show that breast cancer incidence has surpassed ovarian cancer to emerge as the most frequent malignancy in Indian women, with over 1,78,001 new cases being identified each year. Breast cancer, is the most prevalent type of tumor in women, accounting for 14.1% of cancer cases in Indian women. According to reports, a woman in India receives a breast cancer diagnosis every four minutes in both rural and urban areas.

3D Mammography Technology Segment to Gain Largest Market Share Thanks to Increasing Technological Advancements

Owing to ongoing technical advancements, 3D mammography technology held the largest mammography market share in 2021 and is estimated to dominate the market during the forecast period. Additionally, the market is growing due to the increasing adoption of digital breast chemosynthesis equipment as well as the rising utilization of novel breast imaging techniques. Artificial intelligence has been incorporated into 3D mammography to shorten test times without sacrificing image quality. Also, the market expansion over the course of the analysis period is being driven by the FDA’s quick approval of AI-enabled 3D mammogram devices.

Moreover, the incidence of breast cancer is on the rise, and the main causes include obesity, HRT, and aging. The prevalence of breast cancer will increase as more individuals adopt these lifestyles, increasing the need for breast cancer scanning equipment and fuelling the market expansion for mammography systems. Improved insurance reimbursement practices, increasing government support for breast cancer research, and technological breakthroughs like breast computed tomography, makes it easier to find breast cancer in women with dense tissue. Therefore, all these factors are predicted to significantly boost the ASEAN and South Asia mammography systems market during the forecast period.

Leading businesses always work to stay ahead of the competition in the fiercely competitive ASEAN and South Asia mammography systems market by making investments in R&D and putting new ideas into practice. SkyQuest has carried out thorough research utilizing Porter’s Five Forces framework to get insightful knowledge into the industry’s competitive environment. Companies seeking to retain or increase their market share may find this information to be of great value.

Advertisement

Speak to Analyst for your custom requirements:

https://skyquestt.com/speak-with-analyst/mammography-systems-market

Key Developments in the ASEAN and South Asia Mammography Systems Market

  • Canon Medical Systems USA Inc. declared the acquisition of NXC Imaging in July 2022. The strategic partnership will increase Midwest sales and service for Canon Medical Systems US. Canon Medical wanted to establish a sizable service and sales operation in this area that would provide cutting-edge solutions and unique business models.
  • Hologic, Inc. announced the opening of an innovation center in France. This underlines Hologic’s dedication to the EMEA region and comes after its 2019 acquisition of SuperSonic Imagination in Aix-en-Provence. Hologic’s ultrasound, interventional, and surgical solutions will be supported by the new commercial office, training center, and R&D facility.
  • The Goa government began offering free breast cancer screenings to 1 lakh women in October 2021. As part of this initiative, breast cancer scanning will be done at 35 health centers throughout Goa.

Key Questions Answered in the ASEAN and South Asia Mammography Systems Market Research Report

  • What causes are promoting higher investment in the target market, and what effect is this anticipated to have on market expansion over the next few years?
  • What impact will recent technical developments have on consumer behavior in the target market and how will this affect market trends?
  • How can market players profit from the emerging technologies and innovations that are predicted to fuel market growth throughout the forecast period?

Related Reports in SkyQuest’s Library:

Global mHealth Market

Global Digital Therapeutics Market

Advertisement

Global Medical Waste Management Market

Global Electronic Medical Record Market

Global Mammography Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Advertisement

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: [email protected]

Advertisement

LinkedIn Facebook Twitter

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Invitation to the presentation of ASSA ABLOY’s Q3 report on 23 October starting at 09:00am (CEST)

Published

on

invitation-to-the-presentation-of-assa-abloy’s-q3-report-on-23-october-starting-at-09:00am-(cest)

STOCKHOLM, Oct. 1, 2024 /PRNewswire/ — ASSA ABLOY will release its Q3 report 2024 on Wednesday 23 October 2024 at 08:00 am (CEST). A conference call and webcast will be held following the release of the results, starting at 09:00 am (CEST) and continuing until 10:00 am (CEST). The presentation will be hosted by Nico Delvaux, President & CEO, and Erik Pieder, CFO, followed by questions and answers.

Slides used during the presentation will be available shortly after the release of the report on our website.
Enter the conference call and download presentation material at:assaabloy.com/investors
The details for participation by telephone are as follows:
Participants in Sweden should call +46 8 5051 00 31Participants in UK/Europe should call +44 207 107 06 13Participants in US should call +1 631 570 56 13Other international numbers available HEREFor more information, please contact:Isabelle Ewerlöf, Investor Relations Officer, tel: +46 8 506 485 74
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/assa-abloy/r/invitation-to-the-presentation-of-assa-abloy-s-q3-report-on-23-october-starting-at-09-00am–cest-,c4044794
The following files are available for download:
https://mb.cision.com/Public/7333/4044794/87a98230b5054c2e.pdf
Q3 invitation
 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-the-presentation-of-assa-abloys-q3-report-on-23-october-starting-at-0900am-cest-302263614.html

Continue Reading

Artificial Intelligence

Breaking barriers in Operational Technology: Meet Treon Connect

Published

on

breaking-barriers-in-operational-technology:-meet-treon-connect

TAMPERE, Finland, Oct. 1, 2024 /PRNewswire/ — Treon, a leader in IoT technology launches Treon Connect, a platform designed to tackle challenges in operational technology (OT). Founded by innovators with a background in ‘connecting people,’ Treon has evolved to focus on connecting operations, leveraging its expertise in IoT and data acquisition.

Despite industrial digitalization progress, physical operations still face significant challenges. Treon Connect is built to overcome these obstacles, offering businesses the tools to enhance operational efficiency and sustainability.
“Siloed vertical solutions hinder scalability, increase costs and enforce manual workflows” said Joni Korppi, CEO of Treon. “At Treon, we developed Treon Connect to address these challenges, drawing on our experience in delivering IoT solutions for large-scale deployments with 150+ customers, including 50 global leaders.”
Treon Connect works alongside customers’ existing systems, enabling data-driven automation, and helping organizations improve operations by:
Enhancing efficiency: Reducing operational costs and extending asset lifespan through increased uptime and optimal use.Prioritizing worker safety: Reducing downtime and providing safer, more controlled environments.Seamless integration: Integrates with existing IT and OT systems.Minimizing environmental impact: Sustainable products that cut emissions, boost energy efficiency, and reduce waste.As part of Treon Connect, Treon launches:
Treon Apex applications for Condition Monitoring, Fleet Management, Network & Device Management, and Events for workflow automation.Treon Aito, the middleware that securely bridges applications, databases, and systems, is now available on cloud or on-premise, expanding support to third-party devices.Treon Industrial Node X, Treon’s latest wireless vibration sensor, offering market-leading capabilities, such as support for variable-speed machinery and a replaceable battery for sustainabilityTreon Gateway 2, a powerful edge computer, has been updated with cellular coverage for the USA, and telematics support for heavy equipment.Treon will launch Treon Connect at SMRP Annual Conference, October 7-10, 2024, in Orlando, FL, where they will showcase their latest innovations and continue introducing new use cases to enhance operations at a rapid pace together with ecosystem partners.
Visit treon.fi/treon-connect
About Treon
Treon is a leading technology company with a mission to help businesses improve productivity, enhance operational visibility, and sustainability. Its platform, Treon Connect, boosts operational efficiency by utilizing data-driven automation to extend machine lifespan, monitor assets, increase productivity, and ensure safety across industries. Treon is trusted by global leaders to provide secure, customized products that integrate seamlessly into existing business solutions.
Press inquiries
Samah Zain, Senior Growth [email protected]+358-505507331
Photo – https://mma.prnewswire.com/media/2519329/Treon_Connect.jpgLogo – https://mma.prnewswire.com/media/2519328/Treon_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/breaking-barriers-in-operational-technology-meet-treon-connect-302262739.html

Continue Reading

Artificial Intelligence

dsm-firmenich completes the sale of its MEG-3® fish oil business to KD Pharma Group SA

Published

on

dsm-firmenich-completes-the-sale-of-its-meg-3-fish-oil-business-to-kd-pharma-group-sa

KAISERAUGST, Switzerland and MAASTRICHT, Netherlands, Oct. 1, 2024 /PRNewswire/ — dsm-firmenich, innovators in nutrition, health, and beauty, today announces the successful completion of the sale and transfer of its MEG-3® fish oil business for the Food & Beverage, Dietary Supplement and Pharma markets, together with the production facilities in Piura, Peru and Mulgrave, Canada. 

As part of the transaction, dsm-firmenich received a minority stake of 29% in KD Pharma’s parent company MidCo Omega GmbH. 
The sale and transfer of the business was announced on July 18, 2024. Financial details of the transaction will not be disclosed. 
About dsm-firmenichAs innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people. www.dsm-firmenich.com 
For more information
Media relationsRobin Roothanstel. +41 (0)79 280 03 96e-mail [email protected] 
Investor relationsDave Huizingtel. +31 (0)88 425 7306e-mail [email protected]
Forward-looking statementsThis press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
Logo – https://mma.prnewswire.com/media/2071772/dsm_firmenich_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/dsm-firmenich-completes-the-sale-of-its-meg-3-fish-oil-business-to-kd-pharma-group-sa-302262469.html

Continue Reading

Trending